Cancer (Tumor) Profiling Market Report

Global and Region Cancer (Tumor) Profiling Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：137
  • REPORT CODE：GMM971711
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Cancer (Tumor) Profiling market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer (Tumor) Profilingmarket, defines the market attractiveness level of Cancer (Tumor) Profiling market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cancer (Tumor) Profiling industry, describes the types of Cancer (Tumor) Profiling market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer (Tumor) Profiling market and the development prospects and opportunities of Cancer (Tumor) Profiling industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer (Tumor) Profiling market in Chapter 13.

    By Player:

    • Genomic Health

    • Illumina

    • Ribomed Biotechnologies

    • Oxford Gene Technology

    • Neogenomics Laboratories

    • HTG Molecular Diagnostics

    • Caris Life Sciences

    • Nanostring Technologies

    • Qiagen

    • Helomics Corporation

    By Type:

    • Immunoassay

    • Hybridization

    • NGS

    • Mass Spectrometry

    By End-User:

    • Clinical

    • Research

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cancer (Tumor) Profiling Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cancer (Tumor) Profiling Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cancer (Tumor) Profiling Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cancer (Tumor) Profiling Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cancer (Tumor) Profiling Market Analysis and Outlook to 2022

    • 7.1 Global Cancer (Tumor) Profiling Consumption (2017-2022)

    • 7.2 United States Cancer (Tumor) Profiling Consumption (2017-2022)

    • 7.3 Europe Cancer (Tumor) Profiling Consumption (2017-2022)

    • 7.4 China Cancer (Tumor) Profiling Consumption (2017-2022)

    • 7.5 Japan Cancer (Tumor) Profiling Consumption (2017-2022)

    • 7.6 India Cancer (Tumor) Profiling Consumption (2017-2022)

    • 7.7 South Korea Cancer (Tumor) Profiling Consumption (2017-2022)

    8 Region and Country-wise Cancer (Tumor) Profiling Market Analysis and Outlook to 2028

    • 8.1 Global Cancer (Tumor) Profiling Consumption Forecast (2022-2028)

    • 8.2 United States Cancer (Tumor) Profiling Consumption Forecast (2022-2028)

    • 8.3 Europe Cancer (Tumor) Profiling Consumption Forecast (2022-2028)

    • 8.4 China Cancer (Tumor) Profiling Consumption Forecast (2022-2028)

    • 8.5 Japan Cancer (Tumor) Profiling Consumption Forecast (2022-2028)

    • 8.6 India Cancer (Tumor) Profiling Consumption Forecast (2022-2028)

    • 8.7 South Korea Cancer (Tumor) Profiling Consumption Forecast (2022-2028)

    9 Global Cancer (Tumor) Profiling Market Outlook by Types and Applications to 2022

    • 9.1 Global Cancer (Tumor) Profiling Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Immunoassay Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Hybridization Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global NGS Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Mass Spectrometry Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cancer (Tumor) Profiling Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinical Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Research Consumption and Growth Rate (2017-2022)

    10 Global Cancer (Tumor) Profiling Market Outlook by Types and Applications to 2028

    • 10.1 Global Cancer (Tumor) Profiling Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Immunoassay Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Hybridization Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global NGS Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Mass Spectrometry Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cancer (Tumor) Profiling Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinical Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Research Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cancer (Tumor) Profiling Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cancer (Tumor) Profiling Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cancer (Tumor) Profiling Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cancer (Tumor) Profiling Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cancer (Tumor) Profiling Market Competitive Analysis

    • 14.1 Genomic Health

      • 14.1.1 Genomic Health Company Details

      • 14.1.2 Genomic Health Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Genomic Health Cancer (Tumor) Profiling Product and Service

    • 14.2 Illumina

      • 14.2.1 Illumina Company Details

      • 14.2.2 Illumina Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Illumina Cancer (Tumor) Profiling Product and Service

    • 14.3 Ribomed Biotechnologies

      • 14.3.1 Ribomed Biotechnologies Company Details

      • 14.3.2 Ribomed Biotechnologies Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Product and Service

    • 14.4 Oxford Gene Technology

      • 14.4.1 Oxford Gene Technology Company Details

      • 14.4.2 Oxford Gene Technology Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Oxford Gene Technology Cancer (Tumor) Profiling Product and Service

    • 14.5 Neogenomics Laboratories

      • 14.5.1 Neogenomics Laboratories Company Details

      • 14.5.2 Neogenomics Laboratories Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Neogenomics Laboratories Cancer (Tumor) Profiling Product and Service

    • 14.6 HTG Molecular Diagnostics

      • 14.6.1 HTG Molecular Diagnostics Company Details

      • 14.6.2 HTG Molecular Diagnostics Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Product and Service

    • 14.7 Caris Life Sciences

      • 14.7.1 Caris Life Sciences Company Details

      • 14.7.2 Caris Life Sciences Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Caris Life Sciences Cancer (Tumor) Profiling Product and Service

    • 14.8 Nanostring Technologies

      • 14.8.1 Nanostring Technologies Company Details

      • 14.8.2 Nanostring Technologies Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Nanostring Technologies Cancer (Tumor) Profiling Product and Service

    • 14.9 Qiagen

      • 14.9.1 Qiagen Company Details

      • 14.9.2 Qiagen Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Qiagen Cancer (Tumor) Profiling Product and Service

    • 14.10 Helomics Corporation

      • 14.10.1 Helomics Corporation Company Details

      • 14.10.2 Helomics Corporation Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Helomics Corporation Cancer (Tumor) Profiling Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cancer (Tumor) Profiling

    • Figure Cancer (Tumor) Profiling Picture

    • Table Global Cancer (Tumor) Profiling Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer (Tumor) Profiling Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer (Tumor) Profiling Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cancer (Tumor) Profiling Consumption by Country (2017-2022)

    • Figure United States Cancer (Tumor) Profiling Consumption and Growth Rate (2017-2022)

    • Table Europe Cancer (Tumor) Profiling Consumption and Growth Rate (2017-2022)

    • Figure China Cancer (Tumor) Profiling Consumption and Growth Rate (2017-2022)

    • Figure Japan Cancer (Tumor) Profiling Consumption and Growth Rate (2017-2022)

    • Figure India Cancer (Tumor) Profiling Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cancer (Tumor) Profiling Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer (Tumor) Profiling Consumption Forecast by Country (2022-2028)

    • Figure United States Cancer (Tumor) Profiling Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cancer (Tumor) Profiling Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cancer (Tumor) Profiling Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cancer (Tumor) Profiling Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cancer (Tumor) Profiling Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cancer (Tumor) Profiling Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunoassay Consumption and Growth Rate (2017-2022)

    • Figure Global Hybridization Consumption and Growth Rate (2017-2022)

    • Figure Global NGS Consumption and Growth Rate (2017-2022)

    • Figure Global Mass Spectrometry Consumption and Growth Rate (2017-2022)

    • Figure Global Clinical Consumption and Growth Rate (2017-2022)

    • Figure Global Research Consumption and Growth Rate (2017-2022)

    • Figure Global Immunoassay Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hybridization Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NGS Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mass Spectrometry Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cancer (Tumor) Profiling Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cancer (Tumor) Profiling Export by Region (Top 5 Countries) (2017-2028)

    • Table Genomic Health (Foundation Year, Company Profile and etc.)

    • Table Genomic Health Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genomic Health Cancer (Tumor) Profiling Product and Service

    • Table Illumina (Foundation Year, Company Profile and etc.)

    • Table Illumina Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina Cancer (Tumor) Profiling Product and Service

    • Table Ribomed Biotechnologies (Foundation Year, Company Profile and etc.)

    • Table Ribomed Biotechnologies Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ribomed Biotechnologies Cancer (Tumor) Profiling Product and Service

    • Table Oxford Gene Technology (Foundation Year, Company Profile and etc.)

    • Table Oxford Gene Technology Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Oxford Gene Technology Cancer (Tumor) Profiling Product and Service

    • Table Neogenomics Laboratories (Foundation Year, Company Profile and etc.)

    • Table Neogenomics Laboratories Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neogenomics Laboratories Cancer (Tumor) Profiling Product and Service

    • Table HTG Molecular Diagnostics (Foundation Year, Company Profile and etc.)

    • Table HTG Molecular Diagnostics Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table HTG Molecular Diagnostics Cancer (Tumor) Profiling Product and Service

    • Table Caris Life Sciences (Foundation Year, Company Profile and etc.)

    • Table Caris Life Sciences Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Caris Life Sciences Cancer (Tumor) Profiling Product and Service

    • Table Nanostring Technologies (Foundation Year, Company Profile and etc.)

    • Table Nanostring Technologies Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nanostring Technologies Cancer (Tumor) Profiling Product and Service

    • Table Qiagen (Foundation Year, Company Profile and etc.)

    • Table Qiagen Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qiagen Cancer (Tumor) Profiling Product and Service

    • Table Helomics Corporation (Foundation Year, Company Profile and etc.)

    • Table Helomics Corporation Cancer (Tumor) Profiling Sales, Price, Value and Gross Profit (2017-2022)

    • Table Helomics Corporation Cancer (Tumor) Profiling Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US